Rationale and design of a multi-center, open-label, randomised clinical trial comparing HIV incidence and contraceptive benefits in women using three commonly-used contraceptive methods (the ECHO study).
G Justus HofmeyrCharles S MorrisonJared M BaetenTsungai ChipatoDeborah J DonnellPeter GichangiNelly MugoKavita NandaHelen ReesPetrus SteynDouglas Taylornull nullPublished in: Gates open research (2017)
The ECHO study is designed to provide robust evidence on the relative risks (HIV acquisition) and benefits (pregnancy prevention) between three effective contraceptive methods.
Keyphrases
- clinical trial
- open label
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hepatitis c virus
- magnetic resonance
- hiv aids
- hiv testing
- magnetic resonance imaging
- randomized controlled trial
- type diabetes
- metabolic syndrome
- double blind
- diffusion weighted imaging
- computed tomography
- phase iii
- contrast enhanced
- climate change
- preterm birth
- human health
- diffusion weighted